MOLOGEN AG

Release Summary

Dr Matthias Baumann MD will join the Executive Board of biotechnology Company MOLOGEN AG (ISIN DE0006637200, Frankfurt Stock Exchange Prime Standard: MGN) as Chief Medical Officer (CMO) on 1 May 2017.

MOLOGEN AG